Related Experiment Video
Updated: Aug 24, 2026

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
Published on: December 30, 2016
Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells
Kristin Kee1, Slavoljub Vujcic, Salim Merali
1Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
Abstract:
Depletion of intracellular polyamine pools invariably inhibits cell growth. Although this is usually accomplished by inhibiting polyamine biosynthesis, we reasoned that this might be more effectively achieved by activation of polyamine catabolism at the level of spermidine/spermine N(1)-acetyltransferase (SSAT); a strategy first validated in MCF-7 breast carcinoma cells. We now examine the possibility that, due to unique aspects of polyamine homeostasis in the prostate gland, tumor cells derived from it may be particularly sensitive to activated polyamine catabolism. Thus, SSAT was conditionally overexpressed in LNCaP prostate carcinoma cells via a tetracycline-regulatable (Tet-off) system. Tetracycline removal resulted in a rapid approximately 10-fold increase in SSAT mRNA and an increase of approximately 20-fold in enzyme activity. SSAT products N(1)-acetylspermidine, N(1)-acetylspermine, and N(1),N(12)-diacetylspermine accumulated intracellularly and extracellularly. SSAT induction also led to a growth inhibition that was not accompanied by polyamine pool depletion as it was in MCF-7 cells. Rather, intracellular spermidine and spermine pools were maintained at or above control levels by a robust compensatory increase in ornithine decarboxylase and S-adenosylmethionine decarboxylase activities. This, in turn, gave rise to a high rate of metabolic flux through both the biosynthetic and catabolic arms of polyamine metabolism. Treatment with the biosynthesis inhibitor alpha-difluoromethylornithine during tetracycline removal interrupted flux and prevented growth inhibition. Thus, flux-induced growth inhibition appears to derive from overaccumulation of metabolic products and/or from depletion of metabolic precursors. Metabolic effects that were not excluded as possible contributing factors include high levels of putrescine and acetylated polyamines, a 50% reduction in S-adenosylmethionine, and a 45% decline in the SSAT cofactor acetyl-CoA. Overall, the study demonstrates that activation of polyamine catabolism in LNCaP cells elicits a compensatory increase in polyamine biosynthesis and downstream metabolic events that culminate in growth inhibition.
Insights
Activating polyamine catabolism via spermidine/spermine N(1)-acetyltransferase (SSAT) in prostate cancer cells inhibits growth. This occurs through metabolic flux, not polyamine depletion, highlighting a unique cancer vulnerability.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Intracellular polyamine depletion inhibits cell growth.
- Spermidine/spermine N(1)-acetyltransferase (SSAT) activation is a strategy to inhibit cell growth.
- Prostate cancer cells may exhibit unique polyamine homeostasis, suggesting sensitivity to SSAT activation.
Purpose of the Study:
- To investigate the sensitivity of prostate cancer cells (LNCaP) to activated polyamine catabolism via SSAT.
- To elucidate the mechanisms underlying SSAT-induced growth inhibition in prostate cancer cells.
Main Methods:
- Conditional overexpression of SSAT in LNCaP cells using a tetracycline-regulatable (Tet-off) system.
- Measurement of SSAT mRNA, enzyme activity, and polyamine levels.
- Assessment of cell growth inhibition and metabolic flux through polyamine biosynthesis and catabolism pathways.
Main Results:
- SSAT induction in LNCaP cells led to rapid increases in SSAT mRNA and enzyme activity.
- SSAT activation resulted in growth inhibition without polyamine depletion, unlike in MCF-7 cells.
- LNCaP cells exhibited compensatory increases in ornithine decarboxylase and S-adenosylmethionine decarboxylase, maintaining polyamine levels but increasing metabolic flux.
- Inhibition of polyamine biosynthesis during SSAT induction prevented growth inhibition, suggesting flux-induced toxicity.
Conclusions:
- Activation of polyamine catabolism in LNCaP cells triggers compensatory polyamine biosynthesis, leading to significant metabolic flux.
- This flux, rather than polyamine depletion, causes growth inhibition in prostate cancer cells.
- Targeting polyamine metabolism, specifically SSAT, presents a potential therapeutic strategy for prostate cancer.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

